Hyperfine (NASDAQ:HYPR) Earns "Sell (D-)" Rating from Weiss Ratings

Hyperfine (NASDAQ:HYPR - Get Free Report)'s stock had its "sell (d-)" rating reiterated by investment analysts at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

A number of other equities analysts have also recently commented on HYPR. Wells Fargo & Company lifted their target price on shares of Hyperfine from $0.68 to $0.85 and gave the company an "equal weight" rating in a report on Friday, August 15th. Lake Street Capital lifted their target price on shares of Hyperfine from $1.50 to $2.00 and gave the company a "buy" rating in a report on Thursday, August 14th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Hyperfine presently has an average rating of "Hold" and an average target price of $1.28.

Hyperfine Trading Up 21.5%

HYPR stock opened at $2.09 on Wednesday. Hyperfine has a twelve month low of $0.53 and a twelve month high of $2.19. The company's 50 day moving average is $1.33 and its two-hundred day moving average is $0.95. The stock has a market cap of $164.23 million, a P/E ratio of -4.02 and a beta of 1.10.

Hyperfine (NASDAQ:HYPR - Get Free Report) last announced its earnings results on Wednesday, August 13th. The company reported ($0.12) EPS for the quarter, meeting analysts' consensus estimates of ($0.12). The business had revenue of $2.70 million for the quarter, compared to analysts' expectations of $3.00 million. Hyperfine had a negative net margin of 364.54% and a negative return on equity of 84.82%. Hyperfine has set its FY 2025 guidance at EPS. On average, equities research analysts predict that Hyperfine will post -0.57 earnings per share for the current year.

Hedge Funds Weigh In On Hyperfine

Several institutional investors have recently bought and sold shares of the company. AMH Equity Ltd acquired a new position in Hyperfine in the 1st quarter valued at $90,000. Wealth Enhancement Advisory Services LLC boosted its position in shares of Hyperfine by 64.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company's stock worth $72,000 after purchasing an additional 32,093 shares in the last quarter. Finally, EP Wealth Advisors LLC purchased a new stake in shares of Hyperfine during the 1st quarter worth $25,000. 15.03% of the stock is owned by institutional investors and hedge funds.

Hyperfine Company Profile

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.